Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
- DOI
- 10.18553/jmcp.2021.21060
- Published
- 2021 Sep
- Container
- Journal of managed care & specialty pharmacy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.18553/jmcp.2021.21060,
title = {Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.},
author = {Tepper SJ and Fang J and Zhou L and Shen Y and Vo P and Abdrabboh A and Glassberg MB and Ferraris M},
year = {2021},
journal = {Journal of managed care \& specialty pharmacy},
doi = {10.18553/jmcp.2021.21060},
url = {https://doi.org/10.18553/jmcp.2021.21060}
}RIS
TY - JOUR TI - Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States. AU - Tepper SJ AU - Fang J AU - Zhou L AU - Shen Y AU - Vo P AU - Abdrabboh A AU - Glassberg MB AU - Ferraris M PY - 2021 JO - Journal of managed care & specialty pharmacy DO - 10.18553/jmcp.2021.21060 UR - https://doi.org/10.18553/jmcp.2021.21060 ER -
APA
SJ, T., J, F., L, Z., Y, S., P, V., A, A., MB, G., & M, F. (2021). Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2021.21060
Source records
- pubmed · retrieved 2026-09-27T16:07:02.316Z